Hospital de Donostia; Servicio de Oncologia

Guipuzcoa, Guipuzcoa 20014

0 studies enrolling now · 1 studies all time

What they study most

Breast Cancer

Studies at this site

• A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast Cancer — Completed